CY1110444T1 - Μεθοδοι μετατροπης ισομορφων των ιντερφερονων και προϊοντων τους - Google Patents
Μεθοδοι μετατροπης ισομορφων των ιντερφερονων και προϊοντων τουςInfo
- Publication number
- CY1110444T1 CY1110444T1 CY20081101455T CY081101455T CY1110444T1 CY 1110444 T1 CY1110444 T1 CY 1110444T1 CY 20081101455 T CY20081101455 T CY 20081101455T CY 081101455 T CY081101455 T CY 081101455T CY 1110444 T1 CY1110444 T1 CY 1110444T1
- Authority
- CY
- Cyprus
- Prior art keywords
- converting
- present
- interference
- products
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/56—IFN-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Η παρούσα εφεύρεση παρέχει μεθόδους για απομόνωση παρεπόμενων ισόμορφων πρωτεΐνης και μετατροπή τους στην επιθυμούμενη πρωτεΐνη. Σε προτιμούμενες πραγματοποιήσεις, η παρούσα εφεύρεση εξετάζει τη χρήση όξινων διαλυμάτων ή διαλυμάτων ψευδαργύρου για σχάση μιας χημικής ομάδας από την επιθυμούμενη πρωτεΐνη. Σε περαιτέρω προτιμούμενες πραγματοποιήσεις, η παρούσα εφεύρεση εξετάζει την οξείδωση αναγμένων σουλφυδρυλομάδων με σχάση χημικών ομάδων για να σχηματιστεί η λειτουργική επιθυμούμενη πρωτεΐνη.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US19054298A | 1998-11-12 | 1998-11-12 | |
EP99951431A EP1129111B1 (en) | 1998-11-12 | 1999-10-05 | Methods for conversion of interferon isoforms and products thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1110444T1 true CY1110444T1 (el) | 2015-04-29 |
Family
ID=22701766
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20081101455T CY1110444T1 (el) | 1998-11-12 | 2008-12-16 | Μεθοδοι μετατροπης ισομορφων των ιντερφερονων και προϊοντων τους |
CY20101100841T CY1110794T1 (el) | 1998-11-12 | 2010-09-16 | Μεθοδοι μετατροπης ισομορφων ιντερφερονης και προϊοντων της |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20101100841T CY1110794T1 (el) | 1998-11-12 | 2010-09-16 | Μεθοδοι μετατροπης ισομορφων ιντερφερονης και προϊοντων της |
Country Status (27)
Country | Link |
---|---|
EP (2) | EP1894944B1 (el) |
JP (3) | JP4468585B2 (el) |
KR (1) | KR100922454B1 (el) |
CN (2) | CN101255188A (el) |
AR (1) | AR023906A1 (el) |
AT (2) | ATE409706T1 (el) |
AU (1) | AU766309B2 (el) |
BR (1) | BR9915257A (el) |
CA (1) | CA2348739C (el) |
CY (2) | CY1110444T1 (el) |
CZ (2) | CZ302402B6 (el) |
DE (2) | DE69942655D1 (el) |
DK (2) | DK1129111T3 (el) |
ES (2) | ES2348104T3 (el) |
HK (2) | HK1035544A1 (el) |
HU (1) | HU228265B1 (el) |
ID (1) | ID28552A (el) |
IL (2) | IL142546A0 (el) |
NO (2) | NO329483B1 (el) |
NZ (1) | NZ511074A (el) |
PL (2) | PL200274B1 (el) |
PT (2) | PT1129111E (el) |
SI (2) | SI1894944T1 (el) |
SK (2) | SK287564B6 (el) |
TW (1) | TW577894B (el) |
WO (1) | WO2000029440A1 (el) |
ZA (1) | ZA200103010B (el) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU228265B1 (en) * | 1998-11-12 | 2013-02-28 | Merck Sharp & Dohme | Methods of conversion of interferon isoforms and products thereof |
SG172386A1 (en) * | 2008-12-23 | 2011-08-29 | Schering Corp | Purification of recombinantly produced interferon |
EP4139343A4 (en) * | 2020-04-20 | 2024-06-12 | National Research Council of Canada | RECOMBINANT INTERFERON |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NO164037C (no) | 1980-01-08 | 1990-08-22 | Biogen Inc | Fremgangsmaate ved fremstilling av et polypeptid av interferon alfa (ifnalfa)-type. |
US4530901A (en) | 1980-01-08 | 1985-07-23 | Biogen N.V. | Recombinant DNA molecules and their use in producing human interferon-like polypeptides |
US4315852A (en) | 1980-11-26 | 1982-02-16 | Schering Corporation | Extraction of interferon from bacteria |
US4364863A (en) * | 1980-12-29 | 1982-12-21 | Schering Corporation | Extraction of interferon from bacteria |
EP0082481B2 (en) | 1981-12-23 | 1990-09-12 | Schering Corporation | Stabilised alpha-interferon formulations and their preparation |
DE3515336C2 (de) * | 1985-04-27 | 1994-01-20 | Boehringer Ingelheim Int | Verfahren zur Herstellung und Reinigung von â-Interferon |
US4847079A (en) | 1985-07-29 | 1989-07-11 | Schering Corporation | Biologically stable interferon compositions comprising thimerosal |
US4732683A (en) | 1986-12-02 | 1988-03-22 | Biospectrum, Inc. | Purification method for alpha interferon |
US4765903A (en) | 1987-10-06 | 1988-08-23 | Interferon Sciences, Inc. | Purification of monomeric interferon |
US5272135A (en) | 1991-03-01 | 1993-12-21 | Chiron Ophthalmics, Inc. | Method for the stabilization of methionine-containing polypeptides |
AU648214B2 (en) * | 1991-12-31 | 1994-04-14 | Lucky Limited | Recombinant gene coding for human alpha interferon and expression vector thereof, etc. |
ES2161793T3 (es) * | 1994-04-09 | 2001-12-16 | Hoffmann La Roche | Proceso para la produccion de alfa-interferona. |
US5766582A (en) | 1994-10-11 | 1998-06-16 | Schering Corporation | Stable, aqueous alfa interferon solution formulations |
HU228265B1 (en) * | 1998-11-12 | 2013-02-28 | Merck Sharp & Dohme | Methods of conversion of interferon isoforms and products thereof |
-
1999
- 1999-10-05 HU HU0104113A patent/HU228265B1/hu unknown
- 1999-10-05 WO PCT/US1999/020900 patent/WO2000029440A1/en active Application Filing
- 1999-10-05 ES ES07122953T patent/ES2348104T3/es not_active Expired - Lifetime
- 1999-10-05 EP EP07122953A patent/EP1894944B1/en not_active Expired - Lifetime
- 1999-10-05 PT PT99951431T patent/PT1129111E/pt unknown
- 1999-10-05 SK SK5003-2010A patent/SK287564B6/sk not_active IP Right Cessation
- 1999-10-05 AR ARP990105037A patent/AR023906A1/es active IP Right Grant
- 1999-10-05 NZ NZ511074A patent/NZ511074A/en not_active IP Right Cessation
- 1999-10-05 CN CNA2008100866846A patent/CN101255188A/zh active Pending
- 1999-10-05 DK DK99951431T patent/DK1129111T3/da active
- 1999-10-05 PL PL348162A patent/PL200274B1/pl not_active IP Right Cessation
- 1999-10-05 EP EP99951431A patent/EP1129111B1/en not_active Expired - Lifetime
- 1999-10-05 SI SI9931048T patent/SI1894944T1/sl unknown
- 1999-10-05 CZ CZ20011303A patent/CZ302402B6/cs not_active IP Right Cessation
- 1999-10-05 IL IL14254699A patent/IL142546A0/xx unknown
- 1999-10-05 AU AU63870/99A patent/AU766309B2/en not_active Ceased
- 1999-10-05 SI SI9931022T patent/SI1129111T1/sl unknown
- 1999-10-05 CN CNB998132136A patent/CN100390197C/zh not_active Expired - Fee Related
- 1999-10-05 SK SK617-2001A patent/SK287372B6/sk not_active IP Right Cessation
- 1999-10-05 BR BR9915257-6A patent/BR9915257A/pt not_active Application Discontinuation
- 1999-10-05 AT AT99951431T patent/ATE409706T1/de active
- 1999-10-05 KR KR1020017005227A patent/KR100922454B1/ko not_active IP Right Cessation
- 1999-10-05 AT AT07122953T patent/ATE476445T1/de active
- 1999-10-05 DE DE69942655T patent/DE69942655D1/de not_active Expired - Lifetime
- 1999-10-05 CA CA2348739A patent/CA2348739C/en not_active Expired - Fee Related
- 1999-10-05 ES ES99951431T patent/ES2315019T3/es not_active Expired - Lifetime
- 1999-10-05 PT PT07122953T patent/PT1894944E/pt unknown
- 1999-10-05 TW TW088117149A patent/TW577894B/zh not_active IP Right Cessation
- 1999-10-05 CZ CZ20110011A patent/CZ303110B6/cs not_active IP Right Cessation
- 1999-10-05 PL PL385501A patent/PL201341B1/pl not_active IP Right Cessation
- 1999-10-05 DE DE69939657T patent/DE69939657D1/de not_active Expired - Lifetime
- 1999-10-05 ID IDW00200101043A patent/ID28552A/id unknown
- 1999-10-05 DK DK07122953.8T patent/DK1894944T3/da active
- 1999-10-05 JP JP2000582425A patent/JP4468585B2/ja not_active Expired - Fee Related
-
2001
- 2001-04-11 ZA ZA200103010A patent/ZA200103010B/en unknown
- 2001-04-11 IL IL142546A patent/IL142546A/en not_active IP Right Cessation
- 2001-05-11 NO NO20012327A patent/NO329483B1/no not_active IP Right Cessation
- 2001-09-06 HK HK01106287.8A patent/HK1035544A1/xx not_active IP Right Cessation
- 2001-09-06 HK HK08107904.2A patent/HK1112746A1/xx not_active IP Right Cessation
-
2006
- 2006-10-03 JP JP2006272306A patent/JP2006348056A/ja not_active Withdrawn
-
2008
- 2008-12-16 CY CY20081101455T patent/CY1110444T1/el unknown
-
2010
- 2010-05-27 NO NO20100775A patent/NO331699B1/no not_active IP Right Cessation
- 2010-06-17 JP JP2010138760A patent/JP2010209117A/ja not_active Withdrawn
- 2010-09-16 CY CY20101100841T patent/CY1110794T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1105836T1 (el) | 12, 13-τροποποιημενα παραγωγα εποθιλονης | |
CY1117551T1 (el) | Μεθοδος ελεγχου της δραστικοτητας ανοσολογικα λειτουργικου μοριου | |
CY1111042T1 (el) | Μεθοδος απομονωσης βλαστικων κυτταρων | |
DE69736669D1 (de) | Zelladhäsionsinhibitoren | |
CY1106722T1 (el) | Περικαλυμμενη τσικλα | |
DE69633679D1 (de) | Substituierte aryl-oder heteroarylamide mit retinoid-ähnlicher biologischer aktivität | |
FI114422B (fi) | Lähteen puheaktiviteetin tunnistus | |
CY1106992T1 (el) | Καχαλαλιδη f και συναφεις ενωσεις | |
TR200000782T2 (tr) | Resorsinol türevleri. | |
ES2177810T3 (es) | Lamina recubierta de aerogel. | |
DE69918089D1 (de) | Btk inhibitoren und verfahren zur identifizierung und verwendung | |
ATE268379T1 (de) | Enzym mit aminopeptidaseactivität | |
EA200300464A1 (ru) | ГУМАНИЗИРОВАННОЕ АНТИТЕЛО ПРОТИВ РЕЦЕПТОРА ЛИМФОТОКСИНА-β (ВАРИАНТЫ), КОМПОЗИЦИЯ, СПОСОБ ЛЕЧЕНИЯ ИЛИ СНИЖЕНИЯ РИСКА РАЗВИТИЯ, ТЯЖЕСТИ ИЛИ ПОСЛЕДСТВИЙ НЕОПЛАЗИИ У ЧЕЛОВЕКА, ВЫДЕЛЕННАЯ НУКЛЕИНОВАЯ КИСЛОТА (ВАРИАНТЫ), КЛЕТКА КЛЕТОЧНОЙ ЛИНИИ | |
TR200401348T4 (tr) | Yapay elyaf halatların kontrol edilmesi için elektrik kontağı | |
DE69720822D1 (de) | Verwendung von Sprachaktivitätserkennung zur effizienten Sprachkodierung | |
DE69630955T2 (de) | Immortalisierung bzw. desimmortalisierung von zellen | |
CY1110444T1 (el) | Μεθοδοι μετατροπης ισομορφων των ιντερφερονων και προϊοντων τους | |
ES2186807T3 (es) | Inhibidores de trombina. | |
DE69915690D1 (de) | Antikonvulsive derivate zur behandlung von posttraumatischen stresserkrankungen | |
ES2179908T3 (es) | Acidos sacarosamonocarboxilicos acilados. | |
ATE307201T1 (de) | Srcr domäne-enthaltendes protein | |
ATE309371T1 (de) | Protein mit dnase-aktivität | |
ATE238791T1 (de) | Verwendung von 2-methyl-thiazolidin-2,4- dicarbonsäure als mukolytikum | |
ATE222103T1 (de) | Inklusionskomplexe in waessriger loesung | |
GR930100340A (el) | Μέ?οδος για την καταπολέμηση εντόμων. |